Cytoplasmic and nuclear programmed death ligand 1 expression in peritumoral stromal cells in breast cancer: Prognostic and predictive value
- 1Department of Oncology, Orenburg State Medical University, Orenburg 460021, Orenburgskaya Oblast, Russia.
- 2Department of Oncology, Orenburg State Medical University, Orenburg 460021, Orenburgskaya Oblast, Russia. masenchukova@yandex.com.
- 3Department of Pathology, Orenburg Regional Cancer Clinic, Orenburg 460021, Orenburgskaya Oblast, Russia.
- 0Department of Oncology, Orenburg State Medical University, Orenburg 460021, Orenburgskaya Oblast, Russia.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Assessing programmed death ligand 1 (PD-L1) expression in breast cancer (BC) stromal cells, specifically the PDCD1 LG1-positive lymphocyte (PDCD1 LG1+ LF) score, alongside lymphovascular invasion (LVI), improves prediction of metastasis to regional lymph nodes (RLNs).
Area Of Science
- Oncology
- Immunology
- Pathology
Background
- Breast cancer (BC) remains a leading cause of cancer mortality in women.
- Programmed death ligand 1 (PD-L1) is a key marker in BC progression.
- Previous studies focused on PD-L1 in tumor cells; its role in stromal cells requires further investigation.
Purpose Of The Study
- To investigate programmed cell death protein 1 ligand 1 (PDCD1 LG1) expression in BC stromal cells.
- To determine the relationship between PDCD1 LG1 expression in stromal cells and BC clinicopathological characteristics.
Main Methods
- Prospective observational study of 148 newly diagnosed BC patients.
- Immunohistochemical staining for PDCD1 LG1 on tumor samples.
- Assessment of PDCD1 LG1 expression in lymphocytes, polymorphic cell infiltrates, fibroblastic stroma, and endothelial cells.
Main Results
- PDCD1 LG1+ lymphocyte (PDCD1 LG1+ LF) score ≥ 3 was more frequent in stages N0 and N3.
- PDCD1 LG1+ infiltrates and fibroblastic stroma correlated with negative estrogen receptor status, HER2-positive BC, and specific BC subtypes.
- Regional lymph node (RLN) metastasis risk depends on lymphovascular invasion (LVI) and PDCD1 LG1+ LF score.
Conclusions
- Combined assessment of PDCD1 LG1+ LF score and LVI enhances prediction accuracy for RLN metastasis in BC patients.
- This combined approach offers improved prognostic value for BC management.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
02:23
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
01:31
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...

